NOVARTIS has long been suing the Government of India to eliminate or weaken Section 3(d) of the Patents (Amendment) Act, 2005, which established strict standards of patentability in order to prevent the ever-greening of patent monopolies on medicines. Although Novartis lost in 2007 its initial efforts to have Section 3(d) declared unconstitutional and violative of international norms for national patent regimes, it has persisted in appealing and re-appealing the denial...

India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...

The agitation against the Kudankulam nuclear power plant can be seen as a case of activism gone berserk. The high-octane drama against the Kudankulam Nuclear Power Project (KKNPP) in Tamil Nadu has wound down. The seven-month-long agitation led by the People's Movement Against Nuclear Energy (PMANE) at Idinthakarai village in Tirunelveli district, demanding the closure of the ready-to-be commissioned project, ended on March 27 when S.P. Udayakumar, PMANE convener, called off...

Students graduating in law may have to do a stint of compulsory practical training in courts, like the internship that medical graduates have to undergo. Law teachers this newspaper spoke to agreed that such a period of apprenticeship would help new law graduates but argued that it should be kept optional. The original proposal to make legal internship a compulsory part of the five-year LLB course had come from the Chief Justice...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...